BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,782 | -67.9% | 44,983 | -60.5% | 0.00% | – |
| Q2 2023 | $145,906 | +42687.7% | 113,989 | -53.6% | 0.00% | – |
| Q1 2023 | $341 | +7.9% | 245,411 | +0.8% | 0.00% | – |
| Q4 2022 | $316 | -99.8% | 243,401 | +105.6% | 0.00% | – |
| Q3 2022 | $175,000 | -55.2% | 118,379 | -38.3% | 0.00% | – |
| Q2 2022 | $391,000 | -81.1% | 191,856 | +17.6% | 0.00% | -100.0% |
| Q3 2021 | $2,064,000 | +317.8% | 163,131 | +410.2% | 0.00% | – |
| Q2 2021 | $494,000 | – | 31,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $5,183,000 | 2.45% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $3,197,000 | 1.52% |
| Vivo Capital, LLC | 3,871,291 | $10,607,000 | 0.73% |
| Samsara BioCapital, LLC | 1,049,153 | $2,875,000 | 0.72% |
| Novo Holdings A/S | 4,503,991 | $12,341,000 | 0.65% |
| Sofinnova Investments, Inc. | 2,754,437 | $7,547,000 | 0.57% |
| Hawkeye Capital Management, LLC | 415,039 | $1,137,000 | 0.45% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,230,250 | $6,111,000 | 0.19% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1,972,000 | 0.11% |
| Echo Street Capital Management LLC | 123,804 | $5,493,000 | 0.04% |